Palvella Therapeutics Receives Initial Proceeds from FDA Orphan Products Grant to Support Phase 3 SELVA Trial of QTORIN\u2122 Ra

• click to rate

  Posted by Two Blokes Jun 9 - Filed in Stock - 2 views
  
  FDA Orphan Products Grants are awarded based on rigorous scientific and technical review by rare disease and regulatory experts